| Financial Year |
March 31 2023 |
| Monetary Funds |
714,127,343.73 |
| Held-for-trading Financial Assets |
35,482,145.60 |
| Notes Receivable |
19,701,352.82 |
| Accounts Receivable |
417,945,155.31 |
| Advances to Suppliers |
22,101,675.63 |
| Other Receivables |
29,235,388.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
216,356,508.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,314,128.47 |
| Total Current Assets |
1,559,728,554.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
854,053.68 |
| Investment Properties |
-- |
| Fixed Assetes |
324,018,420.24 |
| Under-construction Projects |
253,926,562.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,106,524.35 |
| R&D expenses |
-- |
| Goodwill |
49,120,067.09 |
| Long-Term Deferred and Prepaid Expenses |
44,401,891.46 |
| Deferred Income Tax Assets |
58,823,155.11 |
| Other Non-Current Assets |
14,910,916.03 |
| Sub-Total of Non-Current Assets |
1,039,805,852.51 |
| Total Assets |
2,599,534,407.49 |
| Short-Term Loans |
327,005,902.47 |
| Trading Financial liabilities |
1,202,325.00 |
| Notes Payable |
112,175,858.11 |
| Accounts Payable |
199,785,719.09 |
| Accounts Received In Advance |
209,801.89 |
| Employee Compensation Payable |
35,789,866.33 |
| Taxes Payable |
10,705,134.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
116,314,339.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,956,431.42 |
| Other Current Liabilities |
3,740,522.50 |
| Sub-Total of Current Liabilities |
867,115,834.98 |
| Long-term Loans |
41,554,540.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,853,064.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
129,189,769.94 |
| Total Liabilities |
996,305,604.92 |
| Paid-In Capital(Or Share Stock) |
422,702,739.00 |
| Capital Surplus |
772,450,503.71 |
| Surplus Reserve |
88,044,940.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
314,007,964.11 |
| Minority Stockholder's Interest |
6,304,394.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,596,924,407.68 |
| Owner's Equity（Stockholder's Equity） |
1,603,228,802.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,599,534,407.49 |
